Drug Research logo

The Perspective of Using Flow Cytometry for Unpuzzling Hypoxia-Inducible Factors Signalling

✍🏼 Vishal J. Patel, Amit Joharapurkar, Mukul R. Jain

 

🏠 Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Moraiya, Ahmedabad, India

 

📑 Drug Research (2024)

 

Read the Article

 

Abstract
Hypoxia-inducible factors (HIFs) are transcription factors that are responsible for adapting to the changes in oxygen levels in the cellular environment. HIF activity determines the expression of cellular proteins that control the development and physiology of the cells and pathophysiology of a disease. Understanding the role of specific HIF (HIF-1-3) in cellular function is essential for development of the HIF-targeted therapies. In this review, we have discussed the use of flow cytometry in analysing HIF function in cells. Proper understanding of HIF-signalling will help to design pharmacological interventions HIF-mediated therapy. We have discussed the role of HIF-signalling in various diseases such as cancer, renal and liver diseases, ulcerative colitis, arthritis, diabetes and diabetic complications, psoriasis, and wound healing. We have also discussed protocols that help to decipher the role of HIFs in these diseases that would eventually help to design promising therapies.

Information Hub

Our Blog

Articles about flow cytometry best practices, customer stories, and more.

Industry Events

A dynamic blend of knowledge-sharing, innovation, and networking.

Scientific Content

A library of resources: application notes, webinars, and more.

Publications

Published data generated by WOLF users.

Technical Support

Our dedicated customer support team is here to ensure your success.

Customer Login

A portal of training materials and information for WOLF users.
© 2026 NanoCellect Biomedical. All rights reserved.
Privacy Policy
|
Cookie Policy
|
Terms & Conditions
© 2024 NanoCellect Biomedical. All rights reserved.